Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000912530 | SCV001057640 | likely benign | Dyskeratosis congenita, autosomal recessive 5; Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 3 | 2025-02-02 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV002256595 | SCV002535326 | likely benign | Dyskeratosis congenita | 2021-08-25 | criteria provided, single submitter | curation | |
Ambry Genetics | RCV003169288 | SCV003882103 | likely benign | Inborn genetic diseases | 2022-12-09 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Breakthrough Genomics, |
RCV004704311 | SCV005210184 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Natera, |
RCV001277144 | SCV001463972 | likely benign | Dyskeratosis congenita, autosomal dominant 1 | 2020-04-30 | no assertion criteria provided | clinical testing |